The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke.

Claudio Laudani Davide Capodanno Dominick J Angiolillo

Published in: Expert opinion on pharmacotherapy (2024)

and phosphodiesterase inhibitors, also used in combination, as well as precision medicine approaches using genetic testing aiming at optimizing the safety and efficacy in this population.

Keyphrases

atrial fibrillation